Propofol infusion syndrome and Brugada syndrome electrocardiographic phenocopy

Cardiology Journal

Volumn 17, Issue 2, 2010, Pages 130-135

  Riera, Andŕs Ricardo Ṕrez ^a   Uchida, Augusto Hiroshi ^b   Schapachnik, Edgardo ^c   Dubner, Sergio ^d   Filho, Celso Ferreira ^a   Ferreira, Celso ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d Arrhythmias and Electrophysiology Service   (Argentina)

Author keywords

Adverse effects; Brugada electrocardiographic like pattern; Indications; Phenocopies; Propofol mechanisms

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; DEXMEDETOMIDINE; FENTANYL; LIDOCAINE; MIDAZOLAM; PARACETAMOL; PROPOFOL; SEVOFLURANE; INTRAVENOUS ANESTHETIC AGENT;

ANESTHESIA INDUCTION; APNEA; ARTIFICIAL VENTILATION; BRUGADA SYNDROME; CHRONIC KIDNEY FAILURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG HAIR LEVEL; DRUG MEGADOSE; DYSTONIA; ECG ABNORMALITY; EPILEPTIC STATE; EUPHORIA; GENERAL ANESTHESIA; HALLUCINATION; HEART PROTECTION; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPOTENSION; INJECTION SITE PAIN; INTRAVENOUS ANESTHESIA; LACTIC ACIDOSIS; MYOCLONUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRIAPISM; PROPOFOL INFUSION SYNDROME; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP APNEA SYNDROME; TRAUMATIC BRAIN INJURY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHENOTYPE; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTOR; SHOCK;

ACIDOSIS, LACTIC; ANESTHETICS, INTRAVENOUS; ANIMALS; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; HYPERLIPIDEMIAS; INFUSIONS, INTRAVENOUS; PHENOTYPE; PROPOFOL; RHABDOMYOLYSIS; RISK ASSESSMENT; RISK FACTORS; SHOCK;

EID: 77951194757     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Tan R. Effect of propofol and isoflurane on surgical stress response and postoperative cognitive function in elderly patients. Nan Fang Yi Ke Da Xue Xue Bao, 2009; 29: 1247-1248.
2. Wang B, Shravah J, Luo H et al. Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun, 2009; 389: 105-111.
3. Borchi E, Parri M, Papucci L et al. Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischemia-reperfusion. J Cell Mol Med, 2008; 13: 2724-2735.
4. Laalou FZ, de Vasconcelos AP, Oberling P et al. Involvement of the basal cholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology, 2008; 108: 888-896.
5. Yuzer H, Yuzbasioglu MF, Ciralik H et al. Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren Fail, 2009; 31: 290-296.
6. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience. Crit Care Med, 2009; 37: 3024-3030.
7. Bandschapp O, Ginz HF, Soule CL et al. In vitro effects of propofol and volatile agents on pharmacologically induced chloride channel myotonia. Anesthesiology, 2009; 111: 584-590.
8. Matsukawa K, Nakamoto T, Kadowaki A et al. The enhancing effect of propofol anesthesia on skeletal muscle mechanoreflex in conscious cats Auton Neurosci, 2009; 151: 111-116.
9. Short CE, Bufalari A. Propofol anesthesia. Vet Clin North Am Small Anim Pract, 1999; 29: 747-778.
10. El-Radaideh KM. Effect of pretreatment with lidocaine, intravenous paracetamol and lidocaine-fentanyl on propofol injection pain. Comparative study. Rev Bras Anestesiol, 2007; 57: 32-38.
11. Mahmoud M, Gunter J, Donnelly LF et al. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg, 2009; 109: 745-753.
12. Doufas AG, Morioka N, Mahgoub AN et al. Automated responsiveness monitor to titrate propofol sedation. Anesth Analg, 2009; 109: 778-786.
13. Nimmaanrat S. Myoclonic movements following induction of anesthesia with propofol: A case report. J Med Assoc Thai, 2005; 88: 1955-1997.
14. Mounir K, Bensghir M, Drissi Kamili N. Seizures during intravenous propofol anesthesia. Five cases of seizures during intravenous propofol anesthesia for neurosurgery. Can J Anaesth, 2009; 56: 986-987.
15. Grasshoff C, Herrera-Marschitz M, Goiny M et al. Modulation of ventral pallidal dopamine and glutamate release by the intravenous anesthetic propofol studied by in vivo microdialysis. Amino Acids, 2005; 28: 145-148.
16. Finsterer J. Treatment of mitochondrial disorders. Eur J Paediatr Neurol, 2010; 14: 29-44.
17. Vesta KS, Martina SD, Kozlowski EA. Propofol-induced priapism, a case confirmed with rechallenge Ann Pharmacother, 2006; 40: 980-982.
18. Bonnet U, Harkener J, Scherbaum N.J. A case report of propofol dependence in a physician. Psychoactive Drugs, 2008; 40: 215-217.
19. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: A review of the literature. Fundam Clin Pharmacol, 2007; 21: 459-466.
20. Steele RG, Ajayoglu B. Novel management of propofol induced dystonia in the post anaesthesia care unit. Anaesth Intensive Care, 2007; 35: 138.
21. English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: Pitfalls in diagnosis and prognosis. Anaesthesia, 2009; 64: 908-911.
22. Arpesella R, Dallocchio C, Arbasino C et al. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesth Intensive Care, 2009; 37: 314-318.
23. Otterspoor LC, Kalkman CJ, Cremer OL. Update on the propofol infusion syndrome in ICU management of patients with head injury. Curr Opin Anaesthesiol, 2008; 21: 544-551.
24. Vernooy K, Delhaas T, Cremer OL et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm, 2006; 3: 131-137.
25. Junttila MJ, Gonzalez M, Lizotte E et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation, 2008; 117: 1890-1893.
26. Mali AR, Patil VP, Pramesh CS, Mistry RC. Hyperkalemia during surgery: is it an early warning of propofol infusion syndrome? J Anesth, 2009; 23: 421-423.
27. Robinson JD, Melman Y, Walsh EP. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol, 2008; 31: 1070-1073.
28. Inamura M, Okamoto H, Kuroiwa M et al. General anesthesia for patients with Brugada syndrome. A report of six cases. Can J Anaesth, 2005; 52: 409-412.
29. Riezzo I, Centini F, Neri M et al. Brugada-like EKG pattern and myocardial effects in a chronic propofol abuser. Clin Toxicol (Philadelphia), 2009; 47: 358-363.
30. Miner JR, Burton JH. Clinical practice advisory: Emergency department procedural sedation with propofol. Ann Emer Med, 2007; 50: 182-187.
31. Vernooy K, Vernooy K, Delhaas T et al. Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm, 2006; 3: 131-137.
32. Grant AO. Electrophysiological basis and genetics of Brugada syndrome. J Cardiovasc Electrophysiol, 2005; 1: S3-S7.
33. Lopez-Barbeito B, Ljuis M, Delgado V et al. Diphenhydramine overdose and Brugada sign. Pacing Clin Electrophysiol. 2005; 28: 730-732.
34. Ortega-Carnicer J, Benezet J, Ruiz-Lorenzo F et al. Transient Brugada-type electrocardiographic abnormalities in renal failure reversed by dialysis. Resuscitation, 2002; 55: 215-219.
35. Cohen RD, Woods HF. Lactic acidosis revisited. Diabetes, 1983; 32: 181-191.